Emerging Technology: Page 2

Roche, Janssen expand collaboration to develop CDx tests for targeted therapies

The collaboration involves numerous companion diagnostics technologies, including immunohistochemistry, digital pathology, next generation sequencing, PCR, and immunoassays.

February 9, 2023

Genetic Technologies, Qiagen forming strategic alliance

Genetic Technologies said the alliance is expected to support the enhancement of its capabilities through software, hardware, consumable, and other technical solutions.

February 1, 2023

Guardant360 CDx breast cancer liquid biopsy test receives FDA approval as companion diagnostic

The Guardant360 CDx blood test uses genomic profiling to identify patients with ESR1 mutations who may benefit from Orserdu therapy.

January 30, 2023

Elaborate closes $10M in financing

The company said its technology enables doctors to contextualize health data and deliver clear, actionable communications about lab results to their patients.

January 26, 2023

Probe measures cell stiffness and traction

Seeking ways to alter the probe's mechanical characteristics after injecting it into a tissue of interest, the researchers settled on hydrogels made of polyethylene glycol, a material approved for human use.

January 25, 2023

Metabolon closes $25M in equity financing

The firm develops metabolomics solutions that advance research, diagnostic, therapeutic development, and precision medicine applications.

January 24, 2023

Most Popular

Quest launches long-COVID testing panels for consumers

Ohio, Kentucky doctors convicted in scheme to bill Medicaid for unnecessary urinalysis testing

RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target

Quest Diagnostics offers suite of services for transplant patients and living donors

Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux

Rapid nirmatrelvir treatment in study reduced long-COVID risk

NovoPath expands LIS for oncology labs

The firm said its NovoPath 360 workflow solutions seamlessly integrate into any instruments, billing systems, electronic medical records, and other third-party systems to provide an efficient way to manage and perform MDx techniques.

January 11, 2023

Quantum-Si launches next-generation single-molecule sequencing platform

According to the firm, the small footprint and lower price of the new platform are aimed at providing greater accessibility to high-resolution sequencing data.

December 20, 2022

Qiagen obtains FDA approval for NSCLC companion diagnostic assay

Therascreen KRAS is a tissue-based polymerase chain reaction (PCR) assay designed to identify NSCLC patients likely to respond to treatment with Mirati Therapeutics’ Krazati (adagrasib).

December 13, 2022

Saliva-based graphene sensor shows high sensitivity in preliminary studies

IdentifySensors Biologics is developing saliva-based digital graphene nanosensor technology that it believes can be more sensitive than PCR in detecting COVID-19.

December 12, 2022

Clinical-grade wearables developer Cardiosense raises $15.1M in Series A financing

The Chicago-based digital health company is leveraging artificial intelligence and multisensor devices to develop tools that enable the early detection of cardiovascular disease.

December 8, 2022

Measuring fitness, disease risk without strenuous testing in the lab

University of Cambridge researchers used a deep neural network to process and extract information from raw sensor data and to predict VO2max, an indicator of fitness and marker of heart disease and mortality risk.

December 1, 2022

Previous Page

Page 2 of 43

Next Page